Press Releases

Novartis key multiple sclerosis product Gilenya approved in China

"It is exciting news for MS patients in China that Gilenya has received fast approval. The approval of Gilenya and the upcoming regulatory review for Mayzent demonstrate our commitment to Chinese patients. We are proud that Gilenya already demonstrated...

Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For Spinal Muscular Atrophy

Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular atrophy (SMA). Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at the...

Huge CPhI P MEC China a direct result of surging manufacturing

Organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The...

Swissport develops state-of-the-art pharma center at its brussels air cargo facility

Swissport is investing in a state-of-the-art air cargo facility at Brussels Airport. While Brussels Airport Company is constructing the building, Swissport has signed a long-term lease and is investing several million euros in equipment and fittings for the new...

INTERPHEX Week Japan 2019 – a leading pharma industry event

Interview with Mr. Masaki Soda, Corporate Officer, and Mr. Kosaku Munetomo, International Sales Manager of Reed Exhibitions Japan Ltd. The 21st INTERPHEX JAPAN 2019 was successfully held in the Tokyo Big Sight Convention Center, Japan from 3rd to 5th of...

New state of the art cleanroom completed by WHP for ADC bio

Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility, designed and built by WHP. This forms a key part of ADC Bio’s construction of a new bioconjugation...

AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio Including Extensive Programs in China

Median Technologies, The Imaging Phenomics Company and AG Mednet have renewed their partnership to use AG Mednet’s global infrastructure for the collection, QC and delivery of medical images and ancillary data in support current and future clinical trials and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read